RA Capital Management

Investment thesis

Evidence-based, science-led investor whose conviction is originated in-house by TechAtlas, a proprietary research group of ~45 (mostly PhD) professionals that maps disease landscapes. Enters clinical programs at Series B or later and often holds through IPO into the public phase.

Notable portfolio

Sector focus